Indian Immunologicals Limited Sustainability Profile
Indian Immunologicals Limited (IIL), headquartered in Hyderabad, India, is a prominent player in the biotechnology and pharmaceutical industry. Founded in 1982, IIL has established itself as a leader in the production of vaccines and biopharmaceuticals, focusing on animal health and human health sectors. The company is renowned for its innovative range of products, including vaccines for livestock and poultry, as well as human vaccines. IIL's commitment to quality and research has led to significant milestones, such as the development of India's first indigenous rabies vaccine. With a strong market position, Indian Immunologicals Limited continues to contribute to public health and animal welfare, making it a trusted name in the immunological landscape.
DitchCarbon Score
How does Indian Immunologicals Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Indian Immunologicals Limited's score of 14 is lower than 90% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Indian Immunologicals Limited's reported carbon emissions
Indian Immunologicals Limited currently does not have available carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges that the company has committed to at this time. As a result, Indian Immunologicals Limited's climate commitments and initiatives remain unclear. The company does not appear to inherit emissions data or reduction targets from a parent organisation, indicating that it operates independently in this regard. In the context of the industry, many companies are increasingly focusing on sustainability and carbon reduction strategies, but specific commitments or actions from Indian Immunologicals Limited have not been disclosed.
How Carbon Intensive is Indian Immunologicals Limited's Industry?
How Carbon Intensive is Indian Immunologicals Limited's Location?
Indian Immunologicals Limited's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Indian Immunologicals Limited has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
